Crossref
Characterization and Overcoming of KRAS-Targeted Therapy Resistance in Resistant Cancer Cell Lines
European Journal of Cancer · 2026-11 · 248 · 117531
DOI: 10.1016/j.ejca.2026.117531 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2026-11. Verfasst von L. Chai und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Chai, L., Zhai, Y., Zhang, Y., Yang, X., Li, Z., Bing, T., & Huang, C. (2026). Characterization and Overcoming of KRAS-Targeted Therapy Resistance in Resistant Cancer Cell Lines. European Journal of Cancer, 248, 117531. https://doi.org/10.1016/j.ejca.2026.117531
Vancouver
Chai L, Zhai Y, Zhang Y, Yang X, Li Z, Bing T, et al. Characterization and Overcoming of KRAS-Targeted Therapy Resistance in Resistant Cancer Cell Lines. European Journal of Cancer. 2026;248:117531. doi:10.1016/j.ejca.2026.117531
BibTeX
@article{Chai2026,
author = {Chai, L. and Zhai, Y. and Zhang, Y. and Yang, X. and Li, Z. and Bing, T. and Huang, C.},
title = {Characterization and Overcoming of KRAS-Targeted Therapy Resistance in Resistant Cancer Cell Lines},
journal = {European Journal of Cancer},
year = {2026},
volume = {248},
pages = {117531},
doi = {10.1016/j.ejca.2026.117531}
}
EUVIMED